Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis
Background: Significant survival benefit of adjuvant imatinib therapy has been observed in gastrointestinal stromal tumor (GIST). However, the impact of neoadjuvant imatinib on prognosis of GIST remains unclear. This meta-analysis aimed to compare the prognostic impact between upfront surgery and ne...
Saved in:
Main Authors: | Zhen Liu (Author), Zimu Zhang (Author), Juan Sun (Author), Jie Li (Author), Ziyang Zeng (Author), Mingwei Ma (Author), Xin Ye (Author), Fan Feng (Author), Weiming Kang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment
by: Isabelle Deshaies, et al.
Published: (2010) -
Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy
by: Omer Weitzner, et al.
Published: (2022) -
Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
by: Adnan Asif Parvez Ghias, et al.
Published: (2018) -
Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery
by: Natalia M. Fontecilla, BA, et al.
Published: (2017) -
Gastrointestinal Stromal Tumor (GIST) presenting as acute abdomen: Image in surgery
by: Med Dheker Touati, et al.
Published: (2023)